^Cady, SG; Sono, M. 1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-3-benzo[b]thienyl-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Archives of Biochemistry and Biophysics. 1991, 291 (2): 326–33. PMID 1952947. doi:10.1016/0003-9861(91)90142-6.
^Metz, R; Duhadaway, J. B.; Kamasani, U; Laury-Kleintop, L; Muller, A. J.; Prendergast, G. C. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Research. 2007, 67 (15): 7082–7. PMID 17671174. doi:10.1158/0008-5472.CAN-07-1872.
^Metz, R; Rust, S; Duhadaway, J. B.; Mautino, M. R.; Munn, D. H.; Vahanian, N. N.; Link, C. J.; Prendergast, G. C. IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan. OncoImmunology. 2012, 1 (9): 1460–1468. PMC 3525601. PMID 23264892. doi:10.4161/onci.21716.
^IDO Inhibitors Emerging as New Players on Checkpoint Blockade Scene. Aug 2017. [2023-03-17]. (原始内容于2018-03-20).